In an effort to tackle increasing concerns of hospital acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in Thailand, authors Yong Rongrungruang, Rongpong Plongla, Suwapan Pleumkanitkul, Viriya Hantrakun, and Thana Khawcharoenporn conducted a comprehensive study, shedding light on the most prevalent causative organisms and their consequential effects on healthcare resources within the country. Their study offers critical findings to influence the management and reduction of healthcare-associated infections, particularly the potent Acinetobacter baumannii.
Conducted at four prominent medical institutions in Bangkok, the study analysed the medical records of 240 patients diagnosed with nosocomial pneumonia (NP), a majority of whom suffered from late-onset NP occurring after five days of hospital stay. Pneumonia cases were notably higher among patients receiving mechanical ventilation support, as around 51% of HAP patients required this apparatus post-diagnosis.
The investigation identified Acinetobacter baumannii as the leading causative pathogen, discovered in approximately 44.2% of patients, followed by Pseudomonas aeruginosa (34.6%), and Klebsiella pneumoniae (28.3%). It is of concern that this leading pathogen also expressed a significant resistance to carbapenem, a common type of antibiotics. The study further indicated that hospital readmissions within 30 days of discharge, due to NP, occurred less than 2% of the time, with subsequent hospital stays averaging at four days.
The outcomes of this study highlight the importance of implementing frequent surveillance strategies for likely organisms behind NP and observing their susceptibility profiles, contributing vital data to bolster HAP/VAP management and lessen the resulting strain on healthcare resources. Regular monitoring of the epidemiology, bacteriology, and healthcare resource usage is indispensable to devise effective prevention and control tactics. Therefore, the authors advocate for consistent updates on these areas of study to appropriately navigate the evolving landscape of NP.
Their findings also offer insight into the nature of our current struggle with bacterial diseases, demonstrating pressing needs for innovative treatment strategies engineered to circumvent antimicrobial resistance. The rising antimicrobial resistance of P. aeruginosa, as indicated in the research, presents an alarming trend that healthcare providers must address to keep the infectious disease under control. Evaluation of rehospitalization rates post-discharge and the required usage of healthcare resources further illustrates the substantial toll these diseases impose on the healthcare system, requiring renewed focus on effective infection prevention and control measures.